Clinical Trial Spotlight: Identifying Lung Cancer Patients Who Respond to Ponatinib episode artwork

EPISODE · Nov 23, 2015 · 2 MIN

Clinical Trial Spotlight: Identifying Lung Cancer Patients Who Respond to Ponatinib

from GRACEcast · host cancerGRACE Meetings

Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible. http://bit.ly/UCponatinib

Episode metadata supplied by the publisher feed · Published Nov 23, 2015

Embed this episode

NOW PLAYING

Clinical Trial Spotlight: Identifying Lung Cancer Patients Who Respond to Ponatinib

0:00 2:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on November 23, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!